Bicara Therapeutics Inc. (BCAX) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ra Capital Management, L.p. entity

Director

$37.79M (3)

—

+$37.79M

4,603,418

6.96%

$107.88M

—

Ryan Cohlhepp

President, COO & Interim CEO

—

$4.60M (29) scheduled

−$4.60M

181,641

0.2745%

$4.26M

−17.9%

Claire Mazumdar

Chief Executive Officer

—

$4.06M (17) scheduled

−$4.06M

362,152

0.5473%

$8.49M

+16.9%

Ivan Hyep

Chief Financial Officer

—

$3.24M (17) scheduled

−$3.24M

129,855

0.1962%

$3.04M

−10.7%

Lara Meisner

Chief Legal Officer

—

$1.87M (5) scheduled

−$1.87M

0

0.0000%

$0.00

—

James E Flynn

10% owner

$1.26M (2)

—

+$1.26M

897,587

1.36%

$21.03M

—

David Raben

Chief Medical Officer

—

$1.15M (8) scheduled

−$1.15M

55,286

0.0835%

$1.30M

+55.7%

Tpg Gp A, LLC entity

Former 10% Owner

—

1,960,425

2.96%

$45.94M

—

Fmr LLC entity

See Remark 1

—

1,115,333

1.69%

$26.14M

—

Biocon Ltd entity

10% owner

—

1,080,775

1.63%

$25.33M

—

FIL Ltd entity

See Remark 1

—

1,013,853

1.53%

$23.76M

—

Kiran Mazumdar-Shaw

Director

—

432,736

0.6539%

$10.14M

—

Bicara Therapeutics Inc.

What the insiders did Net buying

By person